KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Non-Current Assets: 2017-2024

Historic Non-Current Assets for Moderna (MRNA) over the last 8 years, with Dec 2024 value amounting to $6.0 billion.

  • Moderna's Non-Current Assets fell 9.78% to $5.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year decrease of 9.78%. This contributed to the annual value of $6.0 billion for FY2024, which is 25.40% down from last year.
  • Latest data reveals that Moderna reported Non-Current Assets of $6.0 billion as of FY2024, which was down 25.40% from $8.1 billion recorded in FY2023.
  • In the past 5 years, Moderna's Non-Current Assets registered a high of $12.4 billion during FY2022, and its lowest value of $1.0 billion during FY2020.
  • Over the past 3 years, Moderna's median Non-Current Assets value was $8.1 billion (recorded in 2023), while the average stood at $8.9 billion.
  • Per our database at Business Quant, Moderna's Non-Current Assets spiked by 727.53% in 2021 and then plummeted by 34.81% in 2023.
  • Yearly analysis of 5 years shows Moderna's Non-Current Assets stood at $1.0 billion in 2020, then soared by 727.53% to $8.6 billion in 2021, then spiked by 44.53% to $12.4 billion in 2022, then slumped by 34.81% to $8.1 billion in 2023, then decreased by 25.40% to $6.0 billion in 2024.